JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Search results for: 'research area pi3k akt signaling pi3k inhibitors'

B1011 Bafetinib (INNO-406)

2 Citation

Summary: Bcr-Abl/Lyn tyrosine kinase inhibitor

≥57.7 mg/mL
B1402 GZD824

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor,novel orally bioavailable

≥36.25 mg/mL
A3017 Dasatinib (BMS-354825)

4 Citation

Summary: Src and BCR-Abl inhibitor

≥24.4 mg/mL
A8232 Nilotinib(AMN-107)

1 Citation

Target: Bcr-Abl

Summary: Bcr-Abl kinase inhibitor,selective

≥26.5 mg/mL
A2149 Bosutinib (SKI-606)

1 Citation

Target: Bcr-Abl|Src

Summary: Potent Abl/Src kinases

≥26.5 mg/mL
A3660 Nilotinib monohydrochloride monohydrate

Summary: Bcr-Abl inhibitor

≥50 mg/mL
C3677 PD 166326

Summary: receptor tyrosine kinases inhibitor

≤25 mg/mL
B6033 GNF-7

Summary: Type II Bcr-Abl inhibitor

insoluble in EtOH; insoluble in H2O; ≥5.48 mg/mL